<p><strong>Kezar Life Sciences 表示，Kevin Tang 在生效時成為存續公司的首席執行官和唯一董事，因為多位現任董事和高管因合併而辭職。</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管（離職協議）</td>
<td>高管（離職協議）</td>
<td>高管（離職協議）</td>
<td>首席執行官；唯一董事（合併子公司之前）</td>
<td>首席運營官（合併子公司之前）</td>
<td>首席財務官（合併子公司之前）</td>
<td>首席法律官、公司秘書及首席合規官（合併子公司之前）</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時被任命為存續公司的唯一董事和高管</td>
<td>在生效時被任命為存續公司的高管</td>
<td>在生效時被任命為存續公司的高管</td>
<td>在生效時被任命為存續公司的高管</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>Kevin Tang 在生效時是合併子公司的唯一董事，併成為存續公司的唯一董事/高管</td>
<td>成為存續公司的高管</td>
<td>成為存續公司的高管</td>
<td>成為存續公司的高管</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>在生效時擔任合併子公司的唯一董事和首席執行官</td>
<td>在生效時擔任合併子公司的首席運營官</td>
<td>在生效時擔任合併子公司的首席財務官</td>
<td>在生效時擔任合併子公司的首席法律官、公司秘書及首席合規官</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
<p>原始 SEC 文件：Kezar Life Sciences, Inc. [ KZR ] - 8-K -2026 年 5 月 11 日
<strong>免責聲明</strong></p>
<p>這是一個由人工智能生成的摘要。可能包含不準確的信息。請考慮與來源核實重要信息。請注意，此摘要僅基於向 SEC 提交的文件。</p>

<p>Kezar Life Sciences 任命 Kevin Tang 為新任首席執行官和唯一董事，此前由於合併多名董事和高管辭職。這些辭職並非由於意見不合，相關人員已簽署分離協議。Tang 曾擔任合併子公司的唯一董事，將領導存續公司</p>

<p><strong>Kezar Life Sciences said Kevin Tang became Chief Executive Officer and sole director of the surviving company at the Effective Time as multiple current directors and officers resigned in connection with the Merger.</strong></p>
<div class="lb-trans"><p><strong>Kezar Life Sciences 表示，Kevin Tang 在生效時成為存續公司的首席執行官和唯一董事，因為多位現任董事和高管因合併而辭職。</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Individual</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>Role</strong></td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Officer (separation agreement)</td>
<td>Officer (separation agreement)</td>
<td>Officer (separation agreement)</td>
<td>Chief Executive Officer; Sole director (Merger Sub prior)</td>
<td>Chief Operating Officer (Merger Sub prior)</td>
<td>Chief Financial Officer (Merger Sub prior)</td>
<td>Chief Legal Officer, Corporate Secretary and Chief Compliance Officer (Merger Sub prior)</td>
</tr>
<tr>
<td><strong>Type of Change</strong></td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Terminated (employment) at Effective Time</td>
<td>Terminated (employment) at Effective Time</td>
<td>Terminated (employment) at Effective Time</td>
<td>Appointed as sole director and officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
<td>Appointed as officer of Surviving Corporation at Effective Time</td>
</tr>
<tr>
<td><strong>Effective Date</strong></td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
<td>At the Effective Time</td>
</tr>
<tr>
<td><strong>Reason</strong></td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Resignation in connection with the Merger; not due to disagreements</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Entered into separation agreement; no disagreements with the Company</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
<td>Per Merger Agreement (Merger Sub became Surviving Corporation)</td>
</tr>
<tr>
<td><strong>Replacement Info</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Kevin Tang was sole director of Merger Sub prior to Effective Time and became sole director/officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
<td>Became officer of Surviving Corporation</td>
</tr>
<tr>
<td><strong>Background Details</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Entered separation agreement (previously disclosed Apr 3, 2026)</td>
<td>Served as sole director and CEO of Merger Sub immediately prior to Effective Time</td>
<td>Served as COO of Merger Sub immediately prior to Effective Time</td>
<td>Served as CFO of Merger Sub immediately prior to Effective Time</td>
<td>Served as Chief Legal Officer, Corporate Secretary and Chief Compliance Officer of Merger Sub immediately prior to Effective Time</td>
</tr>
<tr>
<td><strong>Board/Committee Role Changes</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>John Fowler</td>
<td>Franklin Berger</td>
<td>Graham Cooper</td>
<td>Elizabeth Garner, M.D.</td>
<td>Michael Kauffman, M.D., Ph.D.</td>
<td>Micki Klearman, M.D.</td>
<td>Courtney Wallace</td>
<td>Christopher J. Kirk, Ph.D.</td>
<td>Marc L. Belsky</td>
<td>Mark Schiller</td>
<td>Kevin Tang</td>
<td>Ryan Cole</td>
<td>Michael Hearne</td>
<td>Stephen Robertson</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管（離職協議）</td>
<td>高管（離職協議）</td>
<td>高管（離職協議）</td>
<td>首席執行官；唯一董事（合併子公司之前）</td>
<td>首席運營官（合併子公司之前）</td>
<td>首席財務官（合併子公司之前）</td>
<td>首席法律官、公司秘書及首席合規官（合併子公司之前）</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時終止（僱傭）</td>
<td>在生效時被任命為存續公司的唯一董事和高管</td>
<td>在生效時被任命為存續公司的高管</td>
<td>在生效時被任命為存續公司的高管</td>
<td>在生效時被任命為存續公司的高管</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
<td>在生效時</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>因合併辭職；並非因分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>簽署離職協議；與公司無分歧</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
<td>根據合併協議（合併子公司成為存續公司）</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>Kevin Tang 在生效時是合併子公司的唯一董事，併成為存續公司的唯一董事/高管</td>
<td>成為存續公司的高管</td>
<td>成為存續公司的高管</td>
<td>成為存續公司的高管</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>簽署離職協議（之前於 2026 年 4 月 3 日披露）</td>
<td>在生效時擔任合併子公司的唯一董事和首席執行官</td>
<td>在生效時擔任合併子公司的首席運營官</td>
<td>在生效時擔任合併子公司的首席財務官</td>
<td>在生效時擔任合併子公司的首席法律官、公司秘書及首席合規官</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
</div><p>Original SEC Filing: Kezar Life Sciences, Inc. [ KZR ] - 8-K - May. 11, 2026
<strong>Disclaimer</strong></p>
<div class="lb-trans"><p>原始 SEC 文件：Kezar Life Sciences, Inc. [ KZR ] - 8-K -2026 年 5 月 11 日
<strong>免責聲明</strong></p>
</div><p>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</p>
<div class="lb-trans"><p>這是一個由人工智能生成的摘要。可能包含不準確的信息。請考慮與來源核實重要信息。請注意，此摘要僅基於向 SEC 提交的文件。</p>
</div>

Kevin Tang 被任命為 Kezar Life Sciences 的首席執行官，同時多位董事和高管辭職